This content is machine translated Psoriatic arthritis (PsA) Guselkumab in joint involvement – successful interim results Long-term data from the pivotal DISCOVER-2 study show that treatment with guselkumab resulted in sustained improvements in joint and skin symptoms and functional capacity over a two-year period in biologic-naïve…
View Post 4 min This content is machine translated Neurology New forms of care: Neurology on the road to the future This year’s online congress of the DGN was again a great success. 6700 attendees followed the live program, where 170 speakers presented their papers on site and discussed with each…
View Post 4 min This content is machine translated Personalized PsA therapy Psoriatic arthritis criterion-guided treatment An overarching principle for therapy selection in psoriatic arthritis is shared decision making with patients. The GRAPPA recommendations propose an individualized treatment approach that takes into account the predominant disease…
View Post 3 min This content is machine translated High-risk cardiology patients Facts and Figures on Antithrombotic Therapy Anticoagulation is associated with many challenges – even more so when patients belong to a high-risk group. This is because the combination of different preparations can be associated with risks,…
View Post 4 min This content is machine translated European Society of Cardiology Annual Congress 2021 Evolocumab provides additional benefit for maximal LDL-C reduction “The lower the better” is an important principle for lipid-lowering therapies, and PCSK9 monoclonal antibodies (PCSK9 mAb), such as evolocumab, can effectively lower LDL-C levels [1]. Data from the ECARA…
View Post 5 min This content is machine translated Immunotherapy Untapped potential in early disease stages Over the last decade, immunotherapy using checkpoint inhibitors has become established in the treatment of many oncological conditions. Especially in advanced tumor disease, ipilimumab, nivolumab and co. play a significant…
View Post 3 min This content is machine translated Type 2 diabetics with overweight Dulaglutide in higher dosage additionally promotes weight reduction GLP-1 receptor agonists not only improve glycemic control but also support weight loss and have also demonstrated additional cardio- and neprotective benefits. Dulaglutide (s.c.) has been successfully used for the…
View Post 4 min This content is machine translated Systemic lupus erythematosus Innovative therapeutic approaches on the rise – pioneering new treatment strategies Systemic lupus erythematosus (SLE) carries a high risk of life-threatening organ damage, but there is new hope for sufferers. In recent years, the development of innovative treatment options has been…
View Post 7 min This content is machine translated Dermato-Oncology Intralesional therapy options in focus Sustained progress has been made in dermato-oncology over the last few years. Nevertheless, there are still situations today where symptom control is paramount. Intralesional treatment options can contribute significantly to…
View Post 5 min This content is machine translated Venous thromboembolism Clinical assessment and anticoagulant therapy – an update. If thromboembolism is not detected and treated in time, life-threatening consequences may result. Validated tests, such as the Wells score and the D-dimer test, can be used to assess the…
View Post 4 min This content is machine translated Heart Health Focus on prevention, diagnosis and management of cardiovascular diseases Exciting questions and current research findings related to heart health were discussed at this year’s ESC. The main focus was on prevention strategies, diagnostics and the management of cardiovascular diseases.…
